Cite

HARVARD Citation

    Ceravolo, R. et al. (2016). A review of adverse events linked to dopamine agonists in the treatment of Parkinson's disease. Expert opinion on drug safety. 15 (2), pp. 181-198. [Online]. 
  
Back to record